Product
Personalized drug combination
1 clinical trial
1 indication
Indication
GlioblastomaClinical trial
Individualized Systems Medicine Strategy for Targeting Cancer Stem Cells in Patients With Recurrent Glioblastoma (ISM-GBM)Status: Recruiting, Estimated PCD: 2024-12-01